Dartmouth to launch biomedical research center with NIH grant

The National Institutes of Health (NIH) has awarded $11 million to Dartmouth Medical School in Hanover, N.H., to propel the field of quantitative biology. Its work will look at how genes and the environment combine to cause disease while also assessing ways to employ the combination in coming up with cures.

Dartmouth genetics professor Jason H. Moore, PhD, will serve as principal investigator and oversee the establishment of an NIH Center of Biomedical Research Excellence, according to a Dartmouth satement.

“The goals of the grant include the recruitment of talented young quantitative biologists to Vermont, New Hampshire and Maine, which is essential for advancing biomedical research in our largely rural research setting, and mentoring junior faculty to help them become competitive for NIH funding,” said Moore. “It also will provide funding to junior investigators for research projects, support bioinformatics and biostatistics research through an ‘Integrative Biology Core,’ build infrastructure in the form of a regional, high-performance computing grid, and recruit new faculty in bioinformatics, biostatistics and related areas.”

The work will bring together scientists in multiple disciplines from Dartmouth, the University of New Hampshire, the University of Maine, the University of Vermont, The National Center for Biomedical Computing, the University of Southern Maine, Maine’s Jackson Labs and Mount Desert Island Biological Laboratory and Maine Medical Center.

“Each project pairs an experimental or observational biologist with a quantitative scientist from bioinformatics or biostatistics,” said Moore. “This grant will encourage scientists to collaborate within and between projects, which I believe is the future of biomedical research.”

To read more about Jason Moore and his research, click here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.